Abstract
The use of intravenous amiodarone was assessed during 23 episodes of paroxysmal supraventricular tachycardia in 15 children aged 9 days to 11 years. Five of the fifteen patients had congenital structural heart disease, and three had Wolf-Parkinson-White syndrome. Tachyarrhythmias were returned to sinus rhythm during 20 of the 23 episodes (87%). No major adverse effects occurred. Recurrence of tachycardia was not observed during short-term follow-up. In conclusion, intravenous amiodarone is an effective, safe antiarrhythmic drug for short-term treatment of supraventricular tachycardia in children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bucknall CA, Keeton BR, Curry PV, Tynan MJ, Sutherland GR, et al (1986) Intravenous and oral amiodarone for arrhythmias in children.Br Heart J 56:278–284
Chow AE, Noble-Jamieson C (1989) Termination of paroxysmal supraventricular tachycardia by intravenous adenosine in a child.Anaesthesia 44:322–323
Clarke B, Rowland E, Barnes PJ, Till J, Ward DE, et al (1987) Rapid and safe termination of supraventricular tachycardia in children by adenosine.Lancet 7:299–301
Costigan DC, Holland FJ, Daneman D, Hesslein PS, Vogel M, et al (1986) Amiodarone therapy effects on childhood thyroid function.Pediatrics 77:703–708
Coumel P, Fidelle J (1980) Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.Am Heart J 110:1063–1069
Deal BJ, Keane JF, Gillette PC, Garson A Jr (1985) Wolf-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow up.J Am Coll Cardiol 5:130–135
Garson A Jr (1987) Medicolegal problems in the management of cardiac arrhythmias in children.Pediatrics 79:84–88
Garson A Jr, Gillette PC, McVey P, Hesslein PS, Porter CJ, et al (1984) Amiodarone treatment of critical arrhythmias in children and young adults.J Am Coll Cardiol 3:749–755
Garson A Jr, Moak JP, Smith RT Jr, Norton JB Jr (1987) Usefulness of intravenous propafenone for control of post-operative junctional ectopic tachycardia.Am J Cardiol 59:1422–1424
Giardina AC, Ehlers KH, Engle MA (1972) Wolf-Parkinson-White syndrome in infants and children: a long-term follow-up study.Br Heart J 34:839–846
Kannan R, Yabek SM, Garson A, Miller S, McVey P, et al (1987) Amiodarone efficacy in a young population: relationship to serum amiodarone and desethylamiodarone levels.Am Heart J 114:283–287
Kirk CR, Gibbs JL, Thomas R, Radley-Smith R, Qureshi SA (1987) Cardiovascular collapse after verapamil in supraventricular tachycardia.Arch Dis Child 62:1265–1266
Marcus FI, Fontaine GH, Frank R, Grosgogeat Y (1981) Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodarone.Am Heart J 101:480–493
Mehta AV, Sanchez GR, Sacks EJ, Casta A, Dunn JM, et al (1988) Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.J Am Coll Cardiol 11:379–385
Radford D (1983) Side effects of verapamil in infants.Arch Dis Child 58:465–466
Rosembaum MB, Chiale PA, Halpern MS, Nau GT, Przybyiski J, et al (1976) Clinical efficacy of amiodarone as an anti-arrhythmic agent.Am J Cardiol 38:934–944
Rowland E, Krikler DM (1980) Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.Br Heart J 44:82–91
Scanu P, Grollier G, Guilleman D, Iselin M, Bustany P, et al (1991) Malignant ventricular tachycardia during propafenone treatment in a child with junctional automatic tachycardia: effectiveness of intravenous molar sodium lactate.Pacing Clin Electrophysiol 14:783–786
Shahar E, Barzilay Z, Frand M (1981) Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children.J Pediatr 98:323–327
Shahar E, Barzilay Z, Frand M, Feigl A (1983) Amiodarone in control of sustained tachyarrhythmias in children with Wolf-Parkinson-White syndrome.Pediatrics 72:813–816
Shahar E, Barzilay Z, Shem-Tov AA, Shohet I, Frand M (1983) Pre-excitation syndrome in infants and children: effect of digoxin, verapamil and amiodarone.Arch Dis Child 58:207–211
Sreeram N, Wren C (1990) Supraventricular tachycardia in infants: response to initial treatment.Arch Dis Child 65:127–129
Till JA, Shinebourne EA, Rigby M, Clarke B, Ward DE, et al (1989) Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children.Br Heart J 62:204–211
Till JA, Shinebourne EA, Rowland E, Ward DE, Bhamra R, et al (1989) Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics.Br Heart J 62:133–139
Vignati G, Danzi GB, Austoni P, Fancini P, Mascarello M, et al (1985) La terapia con amiodarone in etá pediatrica: efficacia ed effetti collaterali.G Ital Cardiol 15:786–794
Wellens HJ, Durrer D (1973) Effect of digitalis on atrioventricular conduction and circus movement tachycardias in patients with Wolf-Parkinson-White syndrome.Circulation 47:1229–1233
Wilkinson JL (1983) Management of paroxismal tachycardia.Arch Dis Child 58:945–946
Wolf L, Parkinson J, White PD (1930) Bundle branch block with short PR interval in healthy young people prone to paroxysmal tachycardia.Am Heart J 5:685–704
Woodrow Berson D, Dunnigan A, Benditt DG (1985) Prediction of digoxin treatment failure in infants with supraventricular tachycardia: role of transoesophageal pacing.Pediatrics 75:288–293
Wren C, Campbell RW (1987) The response of paediatric arrhythmias to intravenous and oral flecainide.Br Heart J 57:171–175
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soult, J.A., Muñoz, M., Lopez, J.D. et al. Efficacy and safety of intravenous amiodarone for short-term treatment of paroxysmal supraventricular tachycardia in children. Pediatr Cardiol 16, 16–19 (1995). https://doi.org/10.1007/BF02310328
Issue Date:
DOI: https://doi.org/10.1007/BF02310328